Clinical trial
Study of the Effects of Current Drug Treatments on Levels of Certain Brain…
NCT00104442 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00104442 |
|---|---|
| Title | Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease |
| Official title | Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Rivastigmine |
| Enrollment | 80 |
| Start date | Oct 1, 2003 |
| Completion | Apr 1, 2006 |
| First posted | Mar 1, 2005 |
| Last update posted | Dec 21, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: